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Abstract 
Liquid chiral chromatography of ketoprofen and flurbiprofen enantiomers is carried out using an 
amylose-based stationary phase. The mobile phases used for profens chiral separations are usually a 
hydrocarbon-alcohol combination, with high hydrocarbon content. However, profens show poor 
solubilities in hydrocarbon solvents when compared to alcohols. When the final objective is high 
productivity preparative separations, besides retention time, selectivity and column efficiency, 
solubility of the racemic drug is always a mandatory aspect to take into account. This work shows that 
an increase of the alcoholic content in the mobile phase is possible without a decrease in selectivity 
and column efficiency. Considering the chiral separation of ketoprofen and flurbiprofen enantiomers, 
results show that the mobile phase needs only a small quantity of acidic modifier and can be composed 
by a high or even pure alcoholic content. Additionally, it is found that the type of alcohol to be used 
can differ, depending on the profen racemic mixture to be separated. 
1 Introduction 
The chirality of drugs is an important issue for the pharmaceutical industry, since the different 
enantiomers of a racemic drug may have distinct pharmacological activities, pharmacokinetic and 
pharmacodynamic effects. Because of its chiral selectivity, human body reacts with a racemic drug 
differently, and metabolise each enantiomer on separate pathways producing different 
pharmacological activity. Thus, one isomer may produce the desired therapeutic activities, while the 
other may be inactive or even, in worst cases, produce unwanted effects. Flurbiprofen [2-(2-fluoro-4-
biphenyl)-propionic acid] and ketoprofen [2-(3-benzoylphenyl)-propionic acid] (Figure 1), belong to a 
family of chemicals named 2-arylpropionic acids, or profens, an important sub-class of the frequently 
prescribed and used drugs called nonsteroidal anti-inflammatory drugs (NSAIDs). The main primary 
indications for NSAIDs therapy include rheumatoid arthritis, osteoarthritis, acute gouty arthritis, 
ankylosing spondylitis and dysmenorrhea (DeRuiter, 2002). The importance of profens is supported by 
the fact that, in the last twenty years, drugs like aspirin, phenazone derivatives or acetaminophen are 
being supplemented by profens (Brune and Hinz, 1998). 
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Figure 1. Chemical structures of ketoprofen (a) and flurbiprofen (b). 
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Some studies refer that, while the anti-inflammatory effect and gastric toxicity is associated mainly 
with the S-enantiomers (Wechter et al., 2000), R-enantiomers play a major role in analgesia (Bertini 
and Caselli, 1999) being less toxic than the S-enantiomers or the racemic form (Geisslinger and 
Schaible, 1996). The pharmokinetics in terms of absorption, distribution, metabolism, protein binding 
and elimination may be different for the two enantiomers, leading to inter-individual variability in 
clinical response and drug toxicity. Therefore, there is a need for the development of a preparative-
scale separation method for this class of drugs. Due to its good sensitivity, reproducibility and low 
chromatographic interferences, high performance liquid chromatography (HPLC) using chiral 
stationary phases (CSPs) has been the most employed enantioseparation method of profens. The 
phenylcarbamate derivatives of polysaccharides, particularly cellulose and amylose, show high chiral 
recognition when used as CSPs for HPLC (Yashima, 2001). Among the many derivatives, the amylose 
3,5-dimethylphenylcarbamate (e.g. Chiralpak AD, Daicel, Japan) is the most used on the separation of 
profen racemates. Considering the preparative separation of these class of enantiomers, the choice of 
the mobile phase composition is a critical issue, since directly affects the system productivity by 
influencing retention time, selectivity, column efficiency and solubility of the racemate (Fancotte, 
2001). The objective of this work is to study how mobile phase composition, in terms of acidic and 
alcoholic modifiers, influences the profen enantioseparation. 
2 Equipment and Materials 
All analysis were performed on a Jasco HPLC system with an UV-1575 multiwavelength detector set 
at 260 nm, and a Rheodyne 7725(i) injection valve with a 20 µl loop. The column used was an 
amylose tris(3,5-dimethylphenylcarbamate) coated on a 10 µm silica-gel substrate (Chiralpak AD, 250 
mm L  4,6 mm ID) from Daicel Chemical Industries (Japan). Methanol, ethanol, isopropyl alcohol, 
acetonitrile and n-hexane, all HPLC grade, trifluoroacetic acid (TFA) spectrophotometric grade, 1,3,5-
tri-tert-butylbenzene (as non-retained component), racemic flurbiprofen and racemic ketoprofen of 
analytical grade, were all purchased from Sigma (Madrid, Spain). 
3 Results and Discussion 
3.1 Solubility measurements and pressure drop 
Racemic ketoprofen and flurbiprofen were used for solubility measurements in different solvents. 
First, the influence of the composition of a mixture containing ethanol/n-hexane/0.01%TFA was 
studied. Later, ketoprofen solubility was measured in five different pure solvents: n-hexane, 
acetonitrile, isopropyl alcohol, ethanol, and methanol. All former measurements were carried out at 25 
ºC. Additionally, the influence of temperature on ketoprofen solubility was studied for pure ethanol 
and methanol. Figure 2 shows that the alcoholic (ethanol) content in the mobile phase drastically 
influences profen solubility: ketoprofen enantiomers are insoluble in pure n-hexane solvent and 
present high solubility in pure ethanol.  
0
10
20
30
40
50
0 20 40 60 80 100
So
lu
bi
lity
(g 
ke
to
pr
o
fe
n
 
/ 1
00
 
g 
so
lu
tio
n
)
%  EtO H
 
0
0.3
0.6
0.9
1.2
1.5
0 1 2 3 4 5 6 7
∆P
/L
 
(at
m
/cm
)
u
0
 (cm /m in )
 
Figure 2. Effect of the alcoholic content on ketoprofen 
solubility (solvent: ethanol/n-hexane with 0.01%TFA; 
T=25ºC). 
Figure 3. Pressure drop for different solvents: pure 
isopropanol (filled circles), pure ethanol (filled 
squares), pure methanol (open circles), and an 80% n-
hexane/20% ethanol mixture (open squares). All 
solvents with 0.01% TFA. 
a b 
Solubility measurements obtained for different solvents shows that, at 25 ºC, ketoprofen enantiomers 
have increasing solubilities for pure acetonitrile, isopropyl alcohol, ethanol, and methanol. These 
results confirm that racemic drugs have considerably higher solubilities in alcoholic solvents than in 
the traditional mobile phases used in analytical chiral separation, consisting in an alcohol-hydrocarbon 
combination, with a high hydrocarbon content (Miller et al., 1999). Results also shows the expected 
increasing solubilities with temperature.  
Additional solubility measurements were carried out for flurbiprofen enantiomers. Although showing 
lower solubilities than ketoprofen, the flurbiprofen enantiomers present the same increase in solubility 
with the increase of the alcoholic content (data not shown).  
In a preparative scale perspective, it is of crucial importance the pressure drop obtained in the 
adsorbent bed. Figure 3 shows that lower pressure drops are obtained for methanol; lower than for 
ethanol and even lower than for isopropyl alcohol. 
3.2 Effect of acidic modifier 
Concerning the separation of ketoprofen and flurbiprofen enantiomers, the effect of the acidic modifier 
content on the capacity and selectivity (Figures 4 and 5) and on column efficiency (Figures 6 and 7) 
was studied, using a mobile phase composition of 80% n-hexane/20% ethanol with TFA (0, 0.01, 0.05, 
0.10, and 0.15% v/v).  
0
0.5
1
1.5
2
2.5
0 0.03 0.06 0.09 0.12 0.15
ca
pa
ci
ty
 
fa
ct
o
r,
 
k i
%TFA
a
1
1.1
1.2
1.3
1.4
1.5
0 0.03 0.06 0.09 0.12 0.15
se
le
ct
ivi
ty
, 
α
%TFA
b
0
0.25
0.5
0.75
1
1.25
0 0.03 0.06 0.09 0.12 0.15
ca
pa
cit
y 
fa
ct
o
r,
 
k i
%TFA
a
1.3
1.4
1.5
1.6
1.7
1.8
0 0.03 0.06 0.09 0.12 0.15
se
le
ct
ivi
ty
, 
α
%TFA
b
Figure 4. Effect of the acidic modifier content (%TFA) 
on the separation parameters for ketoprofen 
enantiomers: (a) capacity factors (circles for the less 
and squares for the more retained enantiomer); (b) 
selectivity (mobile phase: 80% n-hexane/20% ethanol; 
T=25ºC). 
Figure 5. Effect of the acidic modifier content (%TFA) 
on the separation parameters for flurbiprofen 
enantiomers: (a) capacity factors (circles for the less 
and squares for the more retained enantiomer); (b) 
selectivity (mobile phase: 80% n-hexane/20% ethanol; 
T=25ºC). 
The results clearly show that the introduction of the acidic modifier decrease retention of both 
enantiomers and increase selectivity. However, it was found that a small concentration of TFA 
(0.01%) is enough to ensure separation and no better performances are obtained with higher TFA 
contents. 
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Figure 6. Effect of the acidic modifier content (%TFA) 
on column efficiency for ketoprofen enantiomers: (a) 
less retained; (b) more retained enantiomer (mobile 
phase: 80% n-hexane/20% ethanol with 0, 0.01, 0.05, 
0.10, and 0.15% TFA; T=25ºC). 
Figure 7. Effect of the acidic modifier content (%TFA) 
on column efficiency for flurbiprofen enantiomers: (a) 
less retained; (b) more retained enantiomer (mobile 
phase: 80% n-hexane/20% ethanol with 0, 0.01, 0.05, 
0.10, and 0.15% TFA; T=25ºC). 
This fact is clearly shown in Figures 6 and 7: for both ketoprofen and flurbiprofen enantiomers, the 
column efficiency is low ( 200150 −=HETP  µm) if no TFA is added. Introducing a 0.01% TFA 
content, the HETP  for both profens and both enantiomers varies between 15 and 30 µm. No better 
results are obtained for higher TFA contents. Additional experiments were carried out for a mobile 
phase containing pure methanol and TFA modifier, and a similar conclusion was found: a 0.01% TFA 
content is enough to ensure separation of profen enantiomers on a Chiralpak AD stationary phase. 
3.3 Effect of alcoholic modifier 
3.3.1 Hydrocarbon – alcohol mixtures 
Experiments were carried out using different n-hexane/ethanol ratios: 80/20, 50/50, 35/65, 20/80, 
10/90 (%v/v), and pure ethanol; all mixtures containing 0.01% TFA. The results obtained are 
presented in Figures 8 to 11.  
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Figure 8. Effect of the alcoholic modifier content 
(%EtOH) on the separation parameters for ketoprofen 
enantiomers: (a) capacity factors (circles for the less 
and squares for the more retained enantiomer); (b) 
selectivity (mobile phase: n-hexane/ethanol mixtures, 
with 0.01% TFA; T=25ºC). 
Figure 9. Effect of the alcoholic modifier content 
(%EtOH) on the separation parameters for flurbiprofen 
enantiomers: (a) capacity factors (circles for the less 
and squares for the more retained enantiomer); (b) 
selectivity (mobile phase: n-hexane/ethanol mixtures, 
with 0.01% TFA; T=25ºC). 
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Figure 10. Effect of the alcoholic modifier content 
(%EtOH) on column efficiency for ketoprofen 
enantiomers: (a) less retained; (b) more retained 
enantiomer (mobile phase: n-hexane/ethanol mixtures, 
with 0.01% TFA ; T=25ºC). Ethanol content: 20% 
(open triangles); 50% (filled triangles); 65% (open 
circles); 80% (filled circles); 90% (open squares); 
100% (filled squares). 
Figure 11. Effect of the alcoholic modifier content 
(%EtOH) on column efficiency for flurbiprofen 
enantiomers: (a) less retained; (b) more retained 
enantiomer (mobile phase: n-hexane/ethanol mixtures, 
with 0.01% TFA; T=25ºC). Ethanol content: 20% 
(open triangles); 50% (filled triangles); 65% (open 
circles); 80% (filled circles); 90% (open squares); 
100% (filled squares). 
Analysing Figures 8 and 9, we conclude that retention (capacity factors) diminish with the increment 
of the alcoholic (ethanol) content. However, selectivity remains under relatively constant values. The 
same occurs in terms of column efficiency (Figures 10 and 11). These results reveal that the use of 
pure alcoholic solvents is possible for chiral separations, and beneficial at a preparative scale. 
 
3.3.2 Alcohol – Alcohol mixtures 
The effect of the content of ethanol/methanol mobile phases on separation was studied for both 
ketoprofen and flurbiprofen systems. The study was carried out using different ethanol/methanol 
composition ratios: 0/100, 20/80, 40/60, 60/40, 80/100 and 100/0 (%v/v); all with 0.01%TFA. Figures 
12 and 13 show distinct results respectively for ketoprofen and flurbiprofen enantiomers. 
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Figure 12. Effect of the content of an ethanol/methanol 
mobile phase on the separation parameters for 
ketoprofen enantiomers: (a) capacity factors (circles 
for the less and squares for the more retained 
enantiomer); (b) selectivity (mobile phase: 
ethanol/methanol mixtures, 0.01% TFA; T=25ºC). 
Figure 13. Effect of the content of an ethanol/methanol 
mobile phase on the separation parameters for 
flurbiprofen enantiomers: (a) capacity factors (circles 
for the less and squares for the more retained 
enantiomer); (b) selectivity (mobile phase: 
ethanol/methanol mixtures, 0.01% TFA; T=25ºC). 
For ketoprofen enantiomers, both retention and selectivity generally increase with the increase of the 
ethanol content. Low selectivities and resolutions are obtained for a high methanol content. For 
flurbiprofen enantiomers, the retention of the first enantiomer is only slightly affected by the 
composition of the ethanol/methanol mobile phase, while the retention of the second enantiomer 
increases with the increase of the methanol content. Selectivity also increases with the increment of 
the methanol content. We conclude that the chiral separation of ketoprofen enantiomers can be 
obtained using a pure ethanol mobile phase, while separation of flurbiprofen enantiomers can be better 
accomplished with a pure methanol solvent. Both solutions are obtained with low retentions, which is 
an advantage in a preparative scale perspective. 
Figure 14 shows the correspondent column efficiency ( HETP ) for ketoprofen and flurbiprofen 
enantiomers, using the selected pure alcohol mobile phase.  
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Figure 14. van Deemter curves (column efficiency versus superficial velocity) for: (a) ketoprofen chiral 
separation in pure ethanol; (b) flurbiprofen chiral separation in pure methanol. Circles for the less and squares 
for the more retained enantiomers. Both mobile phases with 0.01% TFA; T=25ºC. 
4 Conclusions 
The mobile phases used for profens chiral separations are usually a hydrocarbon-alcohol combination, 
with a high hydrocarbon content. However, profens show poor solubilities in hydrocarbon solvents. 
When the final objective is the high productivity preparative separations, solubility of the racemic 
drug is of crucial importance. The results presented show that an increase of the alcoholic content in 
the mobile phase is possible without a decrease on selectivity. Considering the preparative production 
of pure profen enantiomers using an amylose-based chiral stationary phase, results show that the 
optimum mobile phase needs only a small quantity of acidic modifier (0.01% TFA) and can be 
obtained under pure alcohol content. The use of pure alcohol solvents increases solubility of the 
racemate and decreases retention time, both advantages in a preparative scale point of view. Besides, 
the use of pure solvents also simplifies its reutilization in a production separation process. Considering 
the chiral separation of profen racemic mixtures, this work shows that the choice of the better mobile 
phase is not a straightforward task. Pure methanol (with a low quantity of TFA acidic modifier) should 
be used to separate flurbiprofen enantiomers: besides higher solubility, the use of methanol presents 
higher selectivity and lower pressure drop. However, considering the separation of ketoprofen 
enantiomers, pure methanol should be replaced by pure ethanol, since the former mobile phase 
presents low selectivities for this system. 
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